New drug helps patients ditch daily calcium pills in hypoparathyroidism study
NCT ID NCT07299838
First seen Jan 11, 2026 · Last updated May 21, 2026 · Updated 20 times
Summary
This study tested a new drug called palopegteriparatide in 90 adults with chronic hypoparathyroidism, a condition where the body doesn't make enough parathyroid hormone. The goal was to see if the drug could help patients stop taking daily calcium and vitamin D supplements. Researchers tracked how long it took for patients to become independent from these supplements and monitored safety over 14 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOPARATHYROIDISM are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Laiko General Hospital
Athens, Attica, 11527, Greece
Conditions
Explore the condition pages connected to this study.